![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 10, 7280-7288, March 10, 2000
,
,
**, and
From the Section on Growth Factors and the § Laboratory
of Developmental and Molecular Immunity, NICHD, and the
Our previous studies have shown that treatment of
PC12 cells with nerve growth factor (NGF) causes a profound
down-regulation of the epidermal growth factor receptor (EGFR) mRNA
and protein. Further, the NGF-induced down-regulation of the EGFR is
under transcriptional control. To elucidate the molecular mechanism of
this down-regulation we have cloned a 2.7-kilobase sequence from the
promoter region of the rat EGFR from a rat P1 library. Six
transcriptional start sites were identified by 5'-rapid amplification of cDNA ends and primer extension. Sequence analysis showed a 62%
overall homology with the human EGFR promoter region. To investigate its transcription, 1.1 kilobases of the 5'-flanking sequence were fused
to a luciferase reporter gene. This sequence exhibited functional promoter activity in transient transfection experiments with PC12, C6,
and CV-1 cells. Treatment of PC12 cells with NGF inhibited promoter
activity. By transfection of promoter deletion constructs, a silencer
element was found between nucleotides
Laboratory of Molecular Biology, Division of Basic Sciences,
NCI, National Institutes of Health, Bethesda, Maryland 20892
260 and
181, and TCC repeat
sequences appeared to be at least partially responsible for the
down-regulation of the EGFR by NGF. Supportive evidence for the
relevance of this sequence was obtained from gel mobility shift assays
and by transfection of TCC mutation constructs. Our results demonstrate
that TCC repeat sequences are required for the down-regulation of rat
EGFR by NGF in PC12 cells and may lead to the identification of the
NGF-responsive transcription factors.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF142153.
This article is dedicated to the memory of Dr. Gordon Guroff, Chief of Section on Growth Factors and Deputy Scientific Director of the NICHD. During his long career, he enriched the field of neuroscience and all of us who had the privilege to know and work with him.
Permanent address: Dept. of Neurosurgery, Tianjin Medical
University General Hospital, 154 AnShan Rd., Tianjin 300052, China.
¶
Present address: Dept. of Pathology, National Institute of
Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158, Japan.
**
To whom correspondence should be addressed: Bldg. 37, Rm. 2D18,
NCI, National Institutes of Health, Bethesda, MD 20892. Tel.: 301-496-3224; Fax: 301-402-1344; E-mail: aj2e@nih.gov.
Deceased.
This article has been cited by other articles:
![]() |
K. K. Nagothu, A. K. Rishi, R. Jaszewski, O. Kucuk, and A. P. N. Majumdar Folic acid-mediated inhibition of serum-induced activation of EGFR promoter in colon cancer cells Am J Physiol Gastrointest Liver Physiol, September 1, 2004; 287(3): G541 - G546. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Chinni and F. H. Sarkar Akt Inactivation Is a Key Event in Indole-3-carbinol-induced Apoptosis in PC-3 Cells Clin. Cancer Res., April 1, 2002; 8(4): 1228 - 1236. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yu, A. K. Rishi, J. R. Turner, D. Liu, E. D. Black, J. A. Moshier, and A. P. N. Majumdar Cloning of a novel EGFR-related peptide: a putative negative regulator of EGFR Am J Physiol Cell Physiol, May 1, 2001; 280(5): C1083 - C1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-W. Liu, L.-J. Gong, L.-Y. Guo, Y. Katagiri, H. Jiang, Z.-Y. Wang, A. C. Johnson, and G. Guroff The Wilms' Tumor Gene Product WT1 Mediates the Down-regulation of the Rat Epidermal Growth Factor Receptor by Nerve Growth Factor in PC12 Cells J. Biol. Chem., February 9, 2001; 276(7): 5068 - 5073. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |